26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
Finally, an employer-friendly law passed in California! Unfortunately, it only affects a small numbe...
Read More >
Last week, the Chicago City Council passed the Chicago Fair Workweek Ordinance (“the Ordinance”), ...
Read More >
The Committee on Foreign Investment in the United States (“CFIUS”) has now released for public com...
Read More >
On September 14, the U.S. Court of Appeals for the Third Circuit addressed the perennially thorny is...
Read More >
This White Paper highlights some recent developments in certain countries relating to employee stock...
Read More >
United States Citizenship and Immigration Service (USCIS) has implemented a new process for the annu...
Read More >